YBGJ Yubo International Biotech Ltd (QB)

CUSIP No. 988366100

1

NAMES OF REPORTING PERSONS

Cheung Ho Shun 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐

(b)  ☐

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION

Hong Kong 

NUMBER OF

 SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5

SOLE VOTING POWER

7,121,458⁽¹⁾ 

6

SHARED VOTING POWER

0 

7

SOLE DISPOSITIVE POWER

7,121,458⁽¹⁾ 

8

SHARED DISPOSITIVE POWER

0 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

7,121,458 ⁽¹⁾ 

10

Check if the aggregate amount in Row (9) excludes certain shares (See Instructions)

☐ 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.9%⁽²⁾ 

12

TYPE OF REPORTING PERSON (See Instructions)

IN 

⁽¹⁾

Represents (i) 1,755,000 shares of Class A Common Stock held directly by Mr. Cheung Ho Shun, and (ii) 5,366,458 shares of Class A Common Stock held directly by World Precision Medicine Technology Limited, a company organized under the laws of British Virgin Islands (“World Precision”), which is managed and controlled by Mr. Cheung Ho Shun. Mr. Cheung Ho Shun is the President of World Precision, and as such, Mr. Cheung Ho Shun is deemed to have sole voting and investment power over such shares held directly by World Precision.

⁽²⁾

This percentage is based on 119,816,343 shares of Class A Common Stock issued and outstanding, consisting of (i) 118,177,885 shares of Class A Common Stock issued and outstanding as of July 29, 2022, as disclosed in the Issuer’s Prospectus (File No. 333-255805), filed with the U.S. Securities and Exchange Committee (the “SEC”), pursuant to Rule 424(b)(3) under the Securities Act of 1933, as amended, on August 1, 2022; and (ii) 1,638,458 shares of Class A Common Stock newly-issued and sold in a registered offering, as disclosed in the Issuer’s Current Report on Form 8-K, which was filed with the SEC on September 9, 2022.

(a)

Name of Issuer:

Yubo International Biotech Limited

(b)

Address of Issuer’s principal executive offices:

Room 105, Building 5, 31 Xishiku Avenue

Xicheng District, Beijing, China

(a)

Name of person filing:

This Schedule 13G is being filed by Mr. Cheung Ho Shun, as an individual (the “Reporting Person”).

Mr. Cheung Ho Shun directly holds 1,755,000 shares of Class A Common Stock, par value $0.001 per share, of the Issuer. World Precision Medicine Technology Limited, a company organized under the laws of British Virgin Islands (“World Precision”), which is managed and controlled by Mr. Cheung Ho Shun, directly holds 5,366,458 shares of Class A Common Stock. Mr. Cheung Ho Shun is the President of World Precision, and as such, Mr. Cheung Ho Shun is deemed to have the sole voting and investment power over such shares directly held by World Precision.

(b)

Address or principal business office or, if none, residence:

The address of the principal business office of Mr. Cheung Ho Shun is G/f & 1/F 212, Wang Chau Village Extension Area, Ping Shan Yuan Long NT, Hong Kong.

(c)

Citizenship:

Mr. Cheung Ho Shun is a citizen of Hong Kong.

(d)

Title of class of securities:

Class A Common Stock, par value $0.001 per share

(e)

CUSIP No.:

988366100

(a)

☐

(b)

☐

(c)

☐

(d)

☐

(e)

☐

(f)

☐

(g)

☐

(h)

☐

(i)

☐

(j)

☐

(k)

☐

(a)

Amount beneficially owned:

7,121,458

(b)

Percent of class:

5.9%

(c)

Number of shares as to which the person has:

(i)

Sole power to vote or to direct the vote:

7,121,458

(ii)

Shared power to vote or to direct the vote:

0

(iii)

Sole power to dispose or to direct the disposition of:

7,121,458

(iv)

Shared power to dispose or to direct the disposition of:

0